drugset / Trial / NCT00907764
Stress Echocardiography Study With Regadenoson
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
Regadenoson is approved in the US under the brand name Lexiscan for myocardial perfusion imaging. This study will test whether regadenoson is an appropriate stress agent for stress echocardiography.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regadenoson | Diagnostic / imaging agent | 400 ug | — |